People · Operator
Named in public records as an officer, director or promoter · active 2021–2021 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| biOasis Technologies Inc. | — | Biotechnology | Seed | $3.6M | $74.9M | 2021 |
Mei Mei P. Tian at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Mei Mei P. Tian on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Nancy Stagliano | 1 | 5 |
| David M. Wurzer | 1 | 4 |
| Mark Day | 1 | 3 |
| Deborah Rathjen | 1 | 2 |
| May P. Orfali | 1 | 1 |
| John E. Curran | 1 | 1 |
| Dave P. Jenkins | 1 | 1 |
| Deborah P. Rathjen | 1 | 1 |
| Mario E. Saltarelli | 1 | 1 |
| Maha Radhakrishnan | 1 | 1 |
| John E. Hemeon | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.